Ocugen Inc. (NASDAQ: OCGN) is 67.76% higher on its value in year-to-date trading and has touched a low of $0.17 and a high of $3.05 in the current 52-week trading range. The OCGN stock was last observed hovering at around $1.83 in the last trading session, with the day’s gains setting it 1.24% off its average median price target of $1.00 for the next 12 months. It is also -207.0% off the consensus price target high of $1.00 offered by 4 analysts, but current levels are -338.57% lower than the price target low of $0.70 for the same period.
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Currently trading at $3.07, the stock is 255.41% and 484.53% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 167.92 million and changing 67.76% at the moment leaves the stock 697.10% off its SMA200. OCGN registered 469.57% gain for a year compared to 6-month gain of 1302.47%. The firm has a 50-day simple moving average (SMA 50) of $0.6545 and a 200-day simple moving average (SMA200) of $0.4196.
The stock witnessed a 863.89% loss in the last 1 month and extending the period to 3 months gives it a 893.53%, and is 74.43% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.40% over the week and 16.61% over the month.
Ocugen Inc. (OCGN) has around 16 employees, a market worth around $535.50M and $0.04M in sales. Distance from 52-week low is 1705.88% and 0.66% from its 52-week high.
Ocugen Inc. (OCGN) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Ocugen Inc. (OCGN) is a “Overweight”. 4 analysts offering their recommendations for the stock have an average rating of 2.20, where 1 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Ocugen Inc. quarterly earnings per share for the current quarter are estimated at -$0.02.The EPS is expected to grow by 89.60% this year.
Ocugen Inc. (OCGN) Top Institutional Holders
19 institutions hold shares in Ocugen Inc. (OCGN), with 5.29M shares held by insiders accounting for 3.26% while institutional investors hold 13.57% of the company’s shares. The shares outstanding are 162.03M, and float is at 155.85M with Short Float at 3.19%. Institutions hold 13.12% of the Float.
The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 7.44 million shares valued at $2.31 million. The investor’s holdings represent 4.59% of the OCGN Shares outstanding. As of Sep 29, 2020, the second largest holder is Blackrock Inc. with 5.02 million shares valued at $1.56 million to account for 3.10% of the shares outstanding. The other top investors are Geode Capital Management, LLC which holds 0.55 million shares representing 0.34% and valued at over $0.17 million, while Winton Group Ltd. holds 0.23% of the shares totaling 0.37 million with a market value of $0.12 million.
Ocugen Inc. (OCGN) Insider Activity
The most recent transaction is an insider purchase by Castillo Kirsten, the company’s Director. SEC filings show that Castillo Kirsten bought 75,000 shares of the company’s common stock on May 28 at a price of $0.31 per share for a total of $23498.0. Following the purchase, the insider now owns 75000.0 shares.